May 17, 2022
Protected: Nephron Recession Playbook – May 17th 2022
April 28, 2022
Protected: Juan Vallarino on Hospital/Payor Contracting – 4/27/22
April 22, 2022
Protected: Nephron Expert Call: Value Based Care in Medicare: Amy Bassano, HMA and Kelsey Stevens, Wakely – 4/21/22
April 13, 2022
Protected: 340B Tips From Expansion To Contraction – April 13th, 2022
April 13, 2022
Protected: Nephron Legends & Innovators Speaker Series – Dr. Sachin Jain – April 12th, 2022
April 11, 2022
Decade-Long 340B Tailwind Gives Way to Significant Pharmacy Headwind in 1Q 2022
April 11, 2022
Protected: China Diagnostics & Market Update KOL Call
April 7, 2022
March Musings: Community Oncology Event Highlights Busy Month of Research
March 30, 2022
Protected: KOL Views on Biopharma Services for CROs & Tools – REPLAY
March 3, 2022
Protected: Nephron Research Community Oncology Symposium – REPLAY
March 3, 2022
Protected: KOL Views on Lab & COVID Dx Testing w/ Dr. Robert Boorstein at Lenco Labs
February 10, 2022
Toward an Endemic Covid-19 State
February 9, 2022
A Moonshot for LBx: NCI RCT Would Separate MCED Winners & Losers
February 4, 2022
Protected: Nephron Research Private Equity Panel – February 3rd
January 31, 2022
Protected: Healthcare Bull/Bear Debates to Start 2022 – Jan. 28th, 2022